![[IPWatchdog Logo]](https://ipwatchdog.com/wp-content/themes/IPWatchdog%20-%202023/assets/images/temp/logo-small@2x.png){kind=logo}
Gregory Kline, Ph.D.
Senior Director, Transactions, and IP Counsel
Thermo Fisher Scientific
Gregory Kline is Senior Director, Transactions, and IP Counsel at Thermo Fisher Scientific, where he advises on intellectual property, licensing, and complex collaborations in the biotechnology and life sciences sectors. With more than 17 years of experience, his work focuses on resolving legal uncertainty upstream, through IP strategy, regulatory risk clearance, and contracting, to enable customer adoption and reduce downstream friction. He holds a J.D. from UC College of the Law, San Francisco (formerly UC Hastings) and a Ph.D. in Biology/Immunology from UCLA.
The views expressed are his own and do not necessarily reflect those of Thermo Fisher Scientific.
Recent Articles by Gregory Kline, Ph.D.
In re Mitchell: Why the Second AI Didn’t Save Him
Using one associate to prepare a claim construction chart and a second to check it is ordinary practice. In In re Brian E. Mitchell, Proceeding No. D2026-16, a patent attorney did the same with two generative AI tools: one to draft proposed claim constructions and a second to review them. Erroneous citations still reached the district court, and the U.S. Patent and Trademark Office’s (USPTO’s) Office of Enrollment and Discipline (OED) publicly reprimanded him for that.
